Medical manufacturing giant Johnson & Johnson has announced plans to restructure its medical-device businesses after several quarters of declining sales. Johnson & Johnson says it will use the money it saves to fund investments in “new growth opportunities” and new products in the...
Wearable gadgets for tracking health data are becoming increasingly sophisticated in their ability to measure a host of physiologic functions. But the next frontier for innovators will be finding ways to use that data to improve patient outcomes.
One of the nation's leading endocrinologists warns that a so-called "artificial pancreas" touted as a game-changer for the treatment of diabetes could also bring headaches to the industry as it learns how to get reimbursed for advice given in between visits.
U.S. spending to treat heart disease, respiratory ailments and endocrine conditions such as diabetes slowed in the second half of the last decade, but not because fewer people sought care, new data show.
French drugmaker Sanofi is looking to once again beat a rival to the market by redeeming a priority review voucher for faster regulatory review, this time for its experimental combination diabetes drug Lixilan.
Maternal mortality rates in the U.S. are on the rise, and many women are dying from pre-existing health conditions, according to a report by Georgetown University School of Nursing and Health Studies.
More states have improved on most health indicators, according to an annual study that's releasing results for the first time since the Affordable Care Act expanded coverage throughout the country.
A growing list of large U.S. employers that have opened on-site health clinics in an effort to control the rising costs of their health benefit programs. Nearly 30% of firms with more than 5,000 workers now have on-site or near-site clinics offering some type of primary care, up from 24% in 2013.
Data Points for the week of Dec. 7, 2015, covered the following topics: Healthcare costs, diabetes, HealthCare.gov, prescription pain killer addiction, Medicare spending and corporate board compensation
Close to three-quarters of California Medicaid patients identified with having severe mental illness are not being adequately screened for diabetes despite a higher likelihood of chronic disease in that population, a new study found.
Providers and insurers need to do a better job of reaching patients and employers to help private accountable care organizations achieve lower costs and higher quality, according to physician executives at four large health insurance companies.
Jardiance sharply reduced chances of dying in diabetic patients at high risk of heart complications, a study shows, making the medication the first shown to lengthen diabetics' lives.